PSA Density Calculator
Free online PSA density calculator to assess prostate cancer risk. Enter your PSA level in ng/mL and prostate volume in mL for immediate results with clinical interpretation and charts.
About This Calculator
The PSA Density Calculator helps assess prostate cancer risk by dividing your prostate-specific antigen (PSA) level by your prostate volume. This metric provides better specificity than PSA alone, particularly for patients with mildly elevated PSA levels (4-10 ng/mL) where benign prostatic hyperplasia (BPH) may be the cause rather than cancer.
PSA density is calculated using the formula: PSA Density = PSA (ng/mL) / Prostate Volume (mL). The result is expressed in ng/mL². A threshold of 0.15 ng/mL² is most commonly used in clinical practice — values at or above this level raise suspicion for prostate cancer and typically warrant further evaluation with multiparametric MRI or prostate biopsy.
Prostate volume is typically obtained from transrectal ultrasound (TRUS) or multiparametric MRI. The volume is estimated using the ellipsoid formula: V = L × W × H × π/6, where L, W, and H are the prostate dimensions in centimeters. A normal prostate volume ranges from 20-30 mL in young men, increasing with age due to BPH.
The PSA density concept was introduced to overcome the limitation that PSA alone has limited specificity for prostate cancer. Men with larger prostates from BPH naturally produce more PSA, so adjusting for volume helps distinguish cancer from benign enlargement. Clinical studies (Nordström et al., 2018; Jue et al., 2017) have validated PSA density as a useful adjunct in the diagnostic algorithm.
Regional Notes
United States: The NCCN guidelines recommend considering PSA density in men with PSA levels between 3-10 ng/mL to decide on biopsy. The 0.15 ng/mL² threshold is widely adopted. Medicare and most insurers cover PSA screening annually for men over 50.
United Kingdom: NICE guideline NG131 recommends PSA density as part of the risk stratification for prostate cancer. The NHS offers PSA testing to men aged 50+ who request it. PSA density is used alongside multiparametric MRI in the pre-biopsy pathway.
India: PSA testing and PSA density calculation are used in major urology centers across India. The Indian Council of Medical Research (ICMR) recommends shared decision-making for PSA screening starting at age 50, or earlier for those with family history. PSA density helps reduce unnecessary biopsies in the Indian context where BPH is highly prevalent.
Disclaimer: This calculator provides reference information only and is not a substitute for professional medical advice. Always consult a urologist for interpretation of your results.
Frequently Asked Questions
What is PSA density and how is it calculated?
PSA density is calculated by dividing your PSA level (ng/mL) by your prostate volume (mL). The formula is: PSA density = PSA / Prostate Volume. It helps differentiate between prostate cancer and benign prostatic hyperplasia (BPH) in patients with mildly elevated PSA levels.
What is a normal PSA density?
A PSA density below 0.15 ng/mL² is generally considered low risk. Values of 0.15 ng/mL² or higher raise suspicion for prostate cancer and typically warrant further urological evaluation. However, no threshold can completely rule out prostate cancer.
How is prostate volume measured?
Prostate volume is typically measured using transrectal ultrasound (TRUS) or multi-parametric MRI (mpMRI). The volume is calculated using the ellipsoid formula: Volume = Length × Width × Height × π / 6, where dimensions are measured in centimeters.
Can I rely on PSA density alone for prostate cancer diagnosis?
No. PSA density is a screening tool that helps assess risk, but it is not diagnostic. A definitive prostate cancer diagnosis requires a prostate biopsy. Always consult a urologist for proper evaluation, especially if your PSA density is 0.15 ng/mL² or higher.
What is the difference between PSA and PSA density?
PSA is a simple blood test measuring prostate-specific antigen concentration. PSA density adjusts the PSA value by prostate volume, making it more specific. A large prostate from BPH can elevate PSA without cancer; PSA density helps account for this by normalizing for gland size.
Is PSA density used in the US, UK, and India?
Yes, PSA density is used globally in urology practice. In the US, it is recommended by the NCCN for prostate cancer screening decisions. In the UK, NICE guidelines suggest PSA density as part of the diagnostic pathway. In India, leading urology centers use it alongside PSA and DRE for risk stratification.
What conditions can cause elevated PSA besides cancer?
Elevated PSA can result from benign prostatic hyperplasia (BPH), prostatitis (prostate inflammation), urinary tract infection, recent prostate biopsy, catheter insertion, or vigorous physical activity like cycling. This is why PSA density provides additional context by adjusting for prostate size.
What PSA density threshold is used for biopsy decisions?
The most commonly used threshold is 0.15 ng/mL². Some studies suggest using 0.10 ng/mL² for higher sensitivity or 0.20 ng/mL² for higher specificity. Your urologist will consider your age, family history, DRE findings, and previous biopsy results alongside PSA density.